Linda Overholser
Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cancer Survivors | 14 | 2023 | 208 | 4.140 |
Why?
| Neoplasms | 25 | 2023 | 2082 | 2.970 |
Why?
| Survivorship | 13 | 2023 | 41 | 2.660 |
Why?
| Survivors | 14 | 2023 | 414 | 1.190 |
Why?
| Primary Health Care | 8 | 2022 | 1502 | 1.050 |
Why?
| Transition to Adult Care | 2 | 2017 | 60 | 0.990 |
Why?
| Hodgkin Disease | 2 | 2016 | 121 | 0.910 |
Why?
| Patient Acceptance of Health Care | 2 | 2023 | 679 | 0.810 |
Why?
| Neoplasms, Radiation-Induced | 2 | 2020 | 66 | 0.710 |
Why?
| Databases, Factual | 1 | 2023 | 1127 | 0.630 |
Why?
| Anthracyclines | 2 | 2018 | 42 | 0.530 |
Why?
| Cardiovascular Diseases | 2 | 2018 | 1725 | 0.510 |
Why?
| Neoplasms, Second Primary | 1 | 2016 | 92 | 0.500 |
Why?
| Health Services Accessibility | 2 | 2022 | 756 | 0.500 |
Why?
| Practice Guidelines as Topic | 3 | 2020 | 1378 | 0.500 |
Why?
| Quality of Health Care | 2 | 2019 | 572 | 0.490 |
Why?
| Health Planning | 1 | 2015 | 46 | 0.480 |
Why?
| Breast Neoplasms | 4 | 2023 | 1842 | 0.480 |
Why?
| Risk Reduction Behavior | 1 | 2016 | 200 | 0.480 |
Why?
| Radiotherapy | 1 | 2015 | 173 | 0.460 |
Why?
| Rural Population | 3 | 2022 | 441 | 0.450 |
Why?
| Medical Oncology | 4 | 2022 | 229 | 0.430 |
Why?
| Ambulatory Care Facilities | 1 | 2015 | 212 | 0.430 |
Why?
| Quality Improvement | 1 | 2019 | 951 | 0.380 |
Why?
| Quality of Life | 4 | 2023 | 2335 | 0.300 |
Why?
| Humans | 37 | 2023 | 113531 | 0.290 |
Why?
| Early Detection of Cancer | 2 | 2014 | 305 | 0.280 |
Why?
| Survival Rate | 6 | 2016 | 1634 | 0.270 |
Why?
| Interdisciplinary Communication | 2 | 2019 | 183 | 0.260 |
Why?
| Colorectal Neoplasms | 2 | 2009 | 592 | 0.260 |
Why?
| Counseling | 2 | 2018 | 342 | 0.240 |
Why?
| Antineoplastic Agents | 1 | 2015 | 1872 | 0.230 |
Why?
| Colorado | 4 | 2023 | 4061 | 0.230 |
Why?
| Immunization | 4 | 2023 | 397 | 0.220 |
Why?
| Unilateral Breast Neoplasms | 1 | 2023 | 2 | 0.220 |
Why?
| Prophylactic Mastectomy | 1 | 2023 | 5 | 0.210 |
Why?
| Health Promotion | 2 | 2018 | 675 | 0.190 |
Why?
| Young Adult | 5 | 2023 | 10400 | 0.190 |
Why?
| Patient Care Planning | 2 | 2019 | 138 | 0.180 |
Why?
| Tamoxifen | 1 | 2020 | 190 | 0.170 |
Why?
| Guidelines as Topic | 2 | 2019 | 241 | 0.170 |
Why?
| Delivery of Health Care | 2 | 2023 | 828 | 0.160 |
Why?
| Unemployment | 1 | 2019 | 39 | 0.160 |
Why?
| Adult | 10 | 2023 | 30245 | 0.150 |
Why?
| Aged | 4 | 2023 | 18944 | 0.150 |
Why?
| Female | 11 | 2023 | 59115 | 0.150 |
Why?
| Middle Aged | 7 | 2023 | 26552 | 0.140 |
Why?
| United States | 5 | 2022 | 12137 | 0.140 |
Why?
| Electronic Health Records | 1 | 2023 | 801 | 0.140 |
Why?
| Preventive Health Services | 1 | 2018 | 134 | 0.140 |
Why?
| Fertility | 1 | 2017 | 128 | 0.130 |
Why?
| Mass Screening | 4 | 2021 | 978 | 0.130 |
Why?
| Fatigue | 2 | 2014 | 292 | 0.130 |
Why?
| Menopause | 1 | 2017 | 271 | 0.120 |
Why?
| Organizational Innovation | 1 | 2015 | 132 | 0.120 |
Why?
| Sleep Wake Disorders | 2 | 2014 | 223 | 0.110 |
Why?
| Male | 7 | 2023 | 55112 | 0.110 |
Why?
| Surveys and Questionnaires | 2 | 2022 | 4593 | 0.110 |
Why?
| Physicians, Primary Care | 1 | 2016 | 222 | 0.110 |
Why?
| Program Development | 1 | 2015 | 338 | 0.110 |
Why?
| Referral and Consultation | 1 | 2017 | 632 | 0.100 |
Why?
| Communicable Diseases | 1 | 2014 | 124 | 0.100 |
Why?
| Continuity of Patient Care | 1 | 2015 | 252 | 0.100 |
Why?
| Prevalence | 1 | 2018 | 2244 | 0.100 |
Why?
| Life Style | 1 | 2014 | 427 | 0.100 |
Why?
| Mental Health | 1 | 2017 | 559 | 0.100 |
Why?
| Disease Management | 1 | 2015 | 554 | 0.090 |
Why?
| Pain Management | 1 | 2014 | 285 | 0.090 |
Why?
| Patient Satisfaction | 1 | 2015 | 570 | 0.090 |
Why?
| Program Evaluation | 1 | 2015 | 821 | 0.090 |
Why?
| Chronic Pain | 1 | 2014 | 207 | 0.090 |
Why?
| Vaccination | 2 | 2018 | 1198 | 0.090 |
Why?
| Adolescent | 3 | 2019 | 17724 | 0.090 |
Why?
| Cognition Disorders | 1 | 2014 | 476 | 0.090 |
Why?
| Body Weight Maintenance | 2 | 2020 | 15 | 0.080 |
Why?
| Adaptation, Psychological | 1 | 2014 | 546 | 0.080 |
Why?
| Chronic Disease | 1 | 2015 | 1570 | 0.080 |
Why?
| Motor Activity | 1 | 2014 | 623 | 0.080 |
Why?
| Neoplasm Recurrence, Local | 1 | 2014 | 848 | 0.080 |
Why?
| Exercise | 4 | 2022 | 1617 | 0.080 |
Why?
| Brain Neoplasms | 1 | 2014 | 964 | 0.070 |
Why?
| Cross-Sectional Studies | 2 | 2019 | 4400 | 0.060 |
Why?
| Health Personnel | 1 | 2009 | 569 | 0.050 |
Why?
| Aged, 80 and over | 2 | 2015 | 6296 | 0.050 |
Why?
| Mastectomy | 1 | 2023 | 99 | 0.050 |
Why?
| American Cancer Society | 1 | 2022 | 1 | 0.050 |
Why?
| Probability | 1 | 2023 | 285 | 0.050 |
Why?
| Child, Preschool | 1 | 2015 | 9093 | 0.050 |
Why?
| Diet | 2 | 2022 | 1076 | 0.050 |
Why?
| Breast Density | 1 | 2020 | 3 | 0.050 |
Why?
| Organs at Risk | 1 | 2020 | 30 | 0.040 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 1168 | 0.040 |
Why?
| Mammography | 1 | 2020 | 101 | 0.040 |
Why?
| Breast | 1 | 2020 | 138 | 0.040 |
Why?
| Urban Population | 1 | 2022 | 393 | 0.040 |
Why?
| Financing, Personal | 1 | 2019 | 24 | 0.040 |
Why?
| Cardiotoxicity | 1 | 2018 | 27 | 0.040 |
Why?
| Lymphedema | 1 | 2018 | 20 | 0.040 |
Why?
| Self Report | 1 | 2022 | 696 | 0.040 |
Why?
| Antibiotics, Antineoplastic | 1 | 2018 | 109 | 0.040 |
Why?
| Risk Assessment | 2 | 2018 | 2953 | 0.040 |
Why?
| Cost of Illness | 1 | 2019 | 255 | 0.030 |
Why?
| Immunocompromised Host | 1 | 2018 | 190 | 0.030 |
Why?
| Patient Reported Outcome Measures | 1 | 2019 | 251 | 0.030 |
Why?
| Bacterial Infections | 1 | 2018 | 213 | 0.030 |
Why?
| Antineoplastic Agents, Immunological | 1 | 2018 | 152 | 0.030 |
Why?
| Child | 1 | 2015 | 18340 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2020 | 1822 | 0.030 |
Why?
| Public Health | 1 | 2021 | 433 | 0.030 |
Why?
| Virus Diseases | 1 | 2018 | 192 | 0.030 |
Why?
| Models, Organizational | 1 | 2016 | 140 | 0.030 |
Why?
| Societies, Medical | 1 | 2018 | 654 | 0.030 |
Why?
| Cancer Care Facilities | 1 | 2015 | 29 | 0.030 |
Why?
| Biomarkers, Tumor | 1 | 2020 | 1029 | 0.030 |
Why?
| Wakefulness-Promoting Agents | 1 | 2014 | 3 | 0.030 |
Why?
| Treatment Outcome | 2 | 2020 | 9006 | 0.030 |
Why?
| Methylphenidate | 1 | 2014 | 36 | 0.030 |
Why?
| Behavior | 1 | 2014 | 89 | 0.030 |
Why?
| Logistic Models | 1 | 2019 | 1832 | 0.030 |
Why?
| Benzhydryl Compounds | 1 | 2014 | 59 | 0.030 |
Why?
| Weight Reduction Programs | 1 | 2014 | 94 | 0.030 |
Why?
| Occupational Therapy | 1 | 2014 | 74 | 0.030 |
Why?
| Central Nervous System Stimulants | 1 | 2014 | 140 | 0.030 |
Why?
| Patient Education as Topic | 1 | 2014 | 665 | 0.020 |
Why?
| Health Care Surveys | 1 | 2009 | 541 | 0.020 |
Why?
|
|
Overholser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|